Related Experiment Video
Updated: Jan 30, 2026

Overlapping Peptide Library to Map Qa-1 Epitopes in a Protein
Published on: December 20, 2017
Crosstalk between FXR and TGR5 controls glucagon-like peptide 1 secretion to maintain glycemic homeostasis
1Severance Biomedical Science Institute, BK21 PLUS project for Medical Science, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
Abstract:
Though bile acids have been well known as digestive juice, recent studies have demonstrated that bile acids bind to their endogenous receptors, including Farnesoid X receptor (FXR) and G protein-coupled bile acid receptor 1 (GPBAR1; TGR5) and serve as hormone to control various biological processes, including cholesterol/bile acid metabolism, glucose/lipid metabolism, immune responses, and energy metabolism. Deficiency of those bile acid receptors has been reported to induce diverse metabolic syndromes such as obesity, hyperlipidemia, hyperglycemia, and insulin resistance. As consistent, numerous studies have reported alteration of bile acid signaling pathways in type II diabetes patients. Interestingly, bile acids have shown to activate TGR5 in intestinal L cells and enhance secretion of glucagon-like peptide 1 (GLP-1) to potentiate insulin secretion in response to glucose. Moreover, FXR has been shown to crosstalk with TGR5 to control GLP-1 secretion. Altogether, bile acid receptors, FXR and TGR5 are potent therapeutic targets for the treatment of metabolic diseases, including type II diabetes.
Insights
Bile acids act as hormones, regulating metabolism via Farnesoid X receptor (FXR) and TGR5. Targeting these receptors may treat metabolic diseases like type II diabetes.
Area of Science:
- Endocrinology
- Metabolic Diseases
- Molecular Biology
Background:
- Bile acids, traditionally known as digestive juices, are increasingly recognized for their hormonal roles.
- They interact with receptors like Farnesoid X receptor (FXR) and G protein-coupled bile acid receptor 1 (GPBAR1; TGR5), influencing numerous biological processes.
- Dysfunction of these receptors is linked to metabolic disorders such as obesity, hyperlipidemia, hyperglycemia, and insulin resistance.
Purpose of the Study:
- To explore the role of bile acid signaling pathways in metabolic regulation.
- To investigate the therapeutic potential of bile acid receptors (FXR and TGR5) in metabolic diseases, particularly type II diabetes.
Main Methods:
- Review of recent scientific literature on bile acid signaling and metabolic regulation.
- Analysis of studies investigating the interaction between bile acids, their receptors (FXR, TGR5), and metabolic pathways.
- Examination of the link between bile acid signaling alterations and type II diabetes.
Main Results:
- Bile acids function as hormones, modulating cholesterol, glucose, and lipid metabolism, as well as immune and energy balance.
- Deficiency in FXR and TGR5 is associated with the development of metabolic syndromes.
- Activation of TGR5 by bile acids enhances glucagon-like peptide 1 (GLP-1) secretion, improving insulin secretion.
- FXR and TGR5 exhibit crosstalk, collectively influencing GLP-1 secretion.
Conclusions:
- Bile acid receptors FXR and TGR5 play critical roles in maintaining metabolic homeostasis.
- Alterations in bile acid signaling pathways are implicated in type II diabetes.
- FXR and TGR5 represent promising therapeutic targets for managing metabolic diseases, including type II diabetes.
Related Concept Videos
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are...
What is Homeostasis?
Hypoglycemia and Glucagon
pH Homeostasis
Respiratory...
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
Peptide Bonds

